BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11293929)

  • 1. Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels.
    Ushiroyama T; Sakai M; Higashiyama T; Ikeda A; Ueki M
    Gynecol Endocrinol; 2001 Feb; 15(1):74-80. PubMed ID: 11293929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
    Ushiroyama T; Sakuma K; Ikeda A; Ueki M
    J Med; 2004; 35(1-6):281-94. PubMed ID: 18084886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol.
    Gass MS; Rebar RW; Cuffie-Jackson C; Cedars MI; Lobo RA; Shoupe D; Judd HL; Buyalos RP; Clisham PR
    Maturitas; 2004 Oct; 49(2):140-7. PubMed ID: 15474758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
    Kawai H; Furuhashi M; Suganuma N
    Arch Gynecol Obstet; 2004 Mar; 269(3):192-5. PubMed ID: 13680264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral estriol on abnormal plasma FSH and LH concentrations in women with unexplained infertility; conception in a patient with elevated FSH and LH.
    Dmowski WP; Rezai P; Auletta FJ; Scommegna A
    Acta Eur Fertil; 1983; 14(1):23-8. PubMed ID: 6426230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement.
    Limpaphayom K; Taechakraichana N; Kittinunvorakoon C
    J Med Assoc Thai; 1997 Mar; 80(3):147-52. PubMed ID: 9175381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoughts on individualizing hormone replacement therapy based on the postmenopausal health disparities study data.
    Gavaler JS
    J Womens Health (Larchmt); 2003 Oct; 12(8):757-68. PubMed ID: 14588126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Ausmanas MK; Tan DA; Jaisamrarn U; Tian XW; Holinka CF
    Climacteric; 2007 Oct; 10(5):427-37. PubMed ID: 17852146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
    Lai A; Zhang J; Ding L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women.
    Blum I; Vered Y; Lifshitz A; Harel D; Blum M; Nordenberg Y; Harsat A; Sulkes J; Gabbay U; Graff E
    Isr J Med Sci; 1996 Dec; 32(12):1158-62. PubMed ID: 9007144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral estriol on urogenital symptoms, vaginal cytology, and plasma hormone level in postmenopausal women.
    Manonai J; Theppisai U
    J Med Assoc Thai; 2001 Apr; 84(4):539-44. PubMed ID: 11460966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estrogen-progestin replacement therapy on plasma beta-endorphin levels in menopausal women.
    Ortega E; Cuadros JL; Gonzalez AR; Ruiz E
    Biochem Mol Biol Int; 1993 Apr; 29(5):831-6. PubMed ID: 8508135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of hormone therapy in women during postmenopause with the help of Kliogest].
    Bałajewicz M; Mazanek-Mościcka M
    Ginekol Pol; 1996 Nov; 67(11):561-8. PubMed ID: 9289443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.